Bertrand Lebouché - Concepedia

Author

Bertrand Lebouché

Also Known As

B Lebouche, B Lebouché, B Lebouchẻ, B. Lebouche, B. Lebouché, Bertrand LEBOUCHÉ, Bertrand Lebouche, Bertrand Lebouché, I-Score Consulting Team, Jean‐Pierre Routy

229

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

McGill University Health Centre McGill University Université de Montréal Centre Hospitalier de l’Université de Montréal Canadian Institutes of Health Research

About

Bertrand Lebouché is an author at McGill University Health Centre specializing in medicine, public health, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	506
2	Public Health	9	9	351
3	Nursing	4	4	257
4	Social Sciences	2	2	23
5	Epidemiology	2	2	49

Bertrand Lebouché

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis Darrell H. S. Tan, Mark Hull, Deborah Yoong, Canadian Medical Association Journal	2017	221
Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic Khayreddine Bouabida, Bertrand Lebouché, Marie‐Pascale Pomey Healthcare Remote Patient MonitoringDigital Health PlatformsEthical ImpactsCovid-19Telehealth Use	2022	174
Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection Mohammad-Ali Jenabian, Mohamed El‐Far, Kishanda Vyboh, The Journal of Infectious Diseases	2015	124
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients Élise Vuille‐Lessard, Bertrand Lebouché, Lynda Lennox, AIDS	2016	99
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis Marc Deschênes, Bertrand Lebouché, Amine Benmassaoud, Journal of Hepatology Liver FibrosisImmunologyHiv/hcv Co-infected PatientsPathologyFatty Liver Disease	2017	91
Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection Vikram Mehraj, Rayoun Ramendra, Stéphane Isnard, Clinical Infectious Diseases	2019	81
Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion Patrick Miailhes, Mary‐Anne Trabaud, Pierre Pradat, Clinical Infectious Diseases	2007	80
Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of the Engage cohort study Joseph Cox, Herak Apelian, Erica E. M. Moodie, CMAJ Open	2021	79
Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus Stéphane Isnard, Rayoun Ramendra, Franck P. Dupuy, The Journal of Infectious Diseases	2019	77
HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets Rujun Song, Irene Lisovsky, Bertrand Lebouché, PLoS Pathogens	2014	63

Page 1